Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of post-transplant diabetes after renal transplantation
2017-004880-11Phase 2Unknown
- Sponsor
- Barts Health NHS Trust
- Start
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in post-transplantation diabetes mellitus (PTDM) comparing Metformin with Placebo (2 arms). Primary endpoint: Diagnosis of post-transplant diabetes mellitus. Status: unknown.
02
Drugs
metformin
03
Conditions
post-transplantation diabetes mellitus (PTDM)
Beyond the preview
Go deeper on 2017-004880-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004880-11.